"Abstract 16154: Soluble Urokinase Plasminogen Activator Receptor (suPAR) is Associated with Presence and Severity of Coronary Disease and is an Independent Predictor of Adverse Cardiovascular Outcomes" by Danny J Eapen

Article

Abstract 16154: Soluble Urokinase Plasminogen Activator Receptor (suPAR) is Associated with Presence and Severity of Coronary Disease and is an Independent Predictor of Adverse Cardiovascular Outcomes

Circulation (2012)

Danny J Eapen, Emory University
Pankaj Manocha, Emory University
Riyaz S Patel, University College London
Hatem Al Kassem, Emory University
Muhammad Hammadah, Emory University
Ayman Samman Tahhan, Emory University
Nima Ghasemzadeh, Emory University
Mohammad Tarek Kabbany, National Institutes of Health
Mohammad M Asfari
Neal K Bhatia, Emory University
Mohamed Khayata, Emory University
Suliman Alradawi, Emory University
Emir Veledar, Emory University
Tomasz Pielak, University of Copenhagen
Christian W Thorball, University of Copenhagen
Kobina A Wilmot, Emory University
Revanth S Yendamuri, Emory University
Michael M Halista
Ngoc-Anh Le, Emory University
Stamatios Lerakis, Emory University
Laurence Sperling, Emory University
Arshed Quyyumi, Emory University

Link

Disciplines

Publication Date

November 20, 2012

Citation Information

Danny J Eapen, Pankaj Manocha, Riyaz S Patel, Hatem Al Kassem, et al.. "Abstract 16154: Soluble Urokinase Plasminogen Activator Receptor (suPAR) is Associated with Presence and Severity of Coronary Disease and is an Independent Predictor of Adverse Cardiovascular Outcomes" Circulation Vol. 126 (2012)
Available at: http://works.bepress.com/emir-veledar/293/